Cargando…
Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC
Background: Relatively little is known about endocrine function, bone mineral health, and growth during oral iron chelation therapy in β-thalassemia major patients (TM) on treatment with deferasirox. Aims of the study: To study the frequency of endocrine complications, IGF-1 levels and final adult s...
Autores principales: | Soliman, Ashraf T, Yassin, Mohamed A., De Sanctis, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179038/ https://www.ncbi.nlm.nih.gov/pubmed/29451226 http://dx.doi.org/10.23750/abm.v89i2-S.7084 |
Ejemplares similares
-
Cancer research in the 57 Organisation of Islamic Cooperation (OIC) countries, 2008–17
por: Lewison, Grant, et al.
Publicado: (2020) -
Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content
por: Yassin, Mohamed A., et al.
Publicado: (2019) -
3β-Acetoxy-12-oxoolean-28-oic acid benzyl ester
por: Hu, Jun-yi, et al.
Publicado: (2011) -
3α-Hydroxytirucalla-8,24-dien-21-oic acid
por: Yousuf, S., et al.
Publicado: (2011) -
Identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasma
por: Abdel-Khalik, Jonas, et al.
Publicado: (2018)